Sirolimus-Induced Hepatitis in Two Patients with Hyperinsulinemic Hypoglycemia

Sirolimus has been reported to be effective in the treatment of the diffuse form of congenital hyperinsulinism (CHI), unresponsive to diazoxide and octreotide, without causing severe side effects. Two newborns with CHI due to homozygous ABCC8 gene mutations were started on sirolimus aged 21 and 17 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Haliloğlu, Belma, Tüzün, Heybet, Flanagan, Sarah E., Çelik, Muhittin, Kaya, Avni, Ellard, Sian, Özbek, Mehmet Nuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083472/
https://www.ncbi.nlm.nih.gov/pubmed/29217498
http://dx.doi.org/10.4274/jcrpe.5335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083472/
https://www.ncbi.nlm.nih.gov/pubmed/29217498
http://dx.doi.org/10.4274/jcrpe.5335

Ejemplares similares